SavedAdd your journal

Journals / Selcuk Dental Journal / 2021 / Cilt: 8 - Sayı: 3

Evaluation of Serum, Saliva and GCF Visfatin Levels in Chronic Periodontitis Patientswith Uncontrolled /Controlled Type2 Diabetes Mellitus

Kontrol Altında ve Kontrol Altında Olmayan Tip 2 Diyabete SahipKronik Periodontitisli Bireylerde Tükürük, Serum ve GCF VisfatinSeviyelerinin İncelenmesi

Mustafa Cihan YAVUZ
Cenk Fatih ÇANAKÇI
Pages
817–823
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Significant positivecorrelations between GCF visfatin levels and GCF TNF-α andIL-1β levels were detected in (uDM+P+) group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The aim of this study is to investigate visfatinlevels in serum, saliva and GCF samples of non-diabetic CPpatients, CP patients with t2DM and ut2DM, and to evaluateof the relationship with clinical and biochemical parameters ofCP.
📊
Key Findings & Data:Methods: Study protocol, 5 groups which each one wereconsisted of 15 subjects were planned: patients with bothperiodontal and systemic health (DM-P-); CP patients withsystemic health (DM-P+), periodontally healthy patients withdiabetes (DM+P-), patients with diabetes and CP (DM+P+),patients with uncontrolled diabetes and CP (uDM+P+).Serum, saliva and GCF samples were collected and levels ofvisfatin, TNF-α and IL-1β were determined by ELISA.
💡
Conclusion & Impact:Significant positivecorrelations between GCF visfatin levels and GCF TNF-α andIL-1β levels were detected in (uDM+P+) group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: The aim of this study is to investigate visfatinlevels in serum, saliva and GCF samples of non-diabetic CPpatients, CP patients with t2DM and ut2DM, and to evaluateof the relationship with clinical and biochemical parameters ofCP. Methods: Study protocol, 5 groups which each one wereconsisted of 15 subjects were planned: patients with bothperiodontal and systemic health (DM-P-); CP patients withsystemic health (DM-P+), periodontally healthy patients withdiabetes (DM+P-), patients with diabetes and CP (DM+P+),patients with uncontrolled diabetes and CP (uDM+P+).Serum, saliva and GCF samples were collected and levels ofvisfatin, TNF-α and IL-1β were determined by ELISA. Results: The highest levels of visfatin, TNF-α and IL-1β wereseen in (uDM+P+) group (p>0.001). Significant positivecorrelations between GCF visfatin levels and GCF TNF-α andIL-1β levels were detected in (uDM+P+) group (p

Özet

Amaç: Bu çalışmanın amacı, metabolik kontrolleri iyi ve kötü diyabetikkronik periodontitisli hastaların ve non-diyabetik kronik periodontitislihastaların DOS, tükürük ve serum örneklerinde visfatin seviyelerininaraştırılmasıdır. Gereç ve Yöntemler: Bu çalışmada her biri 15 katılımcıdan oluşan 5grup oluşturuldu; sistemik sağlıklı ve periodontal olarak sağlıklıbireylerin oluşturduğu grup (DM-P-), sistemik sağlıklı ve kronikperiodontitisli grup (DM-P+), diyabetli ve periodontal olarak sağlıklıgrup (DM+P-) ile diyabetli ve kronik periodontitisli grup (DM+P+),kontrolsüz diyabetli ve kronik periodontitisli grup (uDM+P+). Serum,tükürük ve DOS örneklerinin alınmasını takiben klinik periodontalparametreler kaydedildi. Lokal ve sistemik visfatin, TNF-α ve IL-1β düzeyleri biyokimyasal olarak ölçüldü. Bulgular: En yüksek visfatin, TNF-α ve IL-1β seviyeleri (uDM+P+)grubunda tespit edildi (p>0.001). (uDM+P+) grubunda DOS visfatinseviyeleri ile DOS TNF-α ve DOS IL-1β seviyeleri arasında istatistikselolarak anlamlı pozitif korelasyonlar tespit edildi (p

🔖

Cite This Article

YAVUZ, M. C., ÇANAKÇI, C. F. (2022). Evaluation of Serum, Saliva and GCF Visfatin Levels in Chronic Periodontitis Patientswith Uncontrolled /Controlled Type2 Diabetes Mellitus. Selcuk Dental Journal, Cilt: 8 - Sayı: 3, 817–823. https://ajindex.com/articles/591395

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Lang, N. P., Schätzle, M. A., & Löe, H. (2009). Gingivitis as a risk factor in periodontal disease. Journal of clinical periodontology, 36, 3-8
  2. Buduneli, N. (2021). Environmental factors and periodontal microbiome. Periodontology 2000, 85(1), 112-125
  3. Genco, R. J., Graziani, F., & Hasturk, H. (2020). Effects of periodontal disease on glycemic control, complications, and incidence of diabetes mellitus. Periodontology 2000, 83(1), 59-65
  4. Gabir, M. M., Hanson, R. L., Dabelea, D., Imperatore, G., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000). The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes care, 23(8), 1108-1112
  5. Löe, H. (1993). Periodontal disease: the sixth complication of diabetes mellitus. Diabetes care, 16(1), 329-334
  6. Grossi, S. G., & Genco, R. J. (1998). Periodontal disease and diabetes mellitus: a two‐way relationship. Annals of periodontology, 3(1), 51-61
  7. Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K.,. & Shimomura, I. (2005). Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 307(5708), 426-430
  8. Ognjanovic, S., Bao, S., Yamamoto, S. Y., GaribayTupas, J., Samal, B., & Bryant-Greenwood, G. D. (2001). Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. Journal of molecular endocrinology, 26(2), 107-118
  9. Moschen, A. R., Kaser, A., Enrich, B., Mosheimer, B., Theurl, M., Niederegger, H., & Tilg, H. (2007). Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. The Journal of Immunology, 178(3), 1748-1758. 10.Hammarstedt, A., Pihlajamäki, J., Rotter Sopasakis, V., Gogg, S., Jansson, P. A., Laakso, M., & Smith, U. (2006). Visfatin is an adipokine, but it is not regulated by thiazolidinediones. The Journal of Clinical Endocrinology & Metabolism, 91(3), 1181-1184. 11.Pradeep, A. R., Raghavendra, N. M., Prasad, M. R., Kathariya, R., Patel, S. P., & Sharma, A. (2011). Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease. Journal of periodontology, 82(9), 1314- 1319. 12.Heo, Y. J., Choi, S. E., Jeon, J. Y., Han, S. J., Kim, D. J., Kang, Y.,. & Kim, H. J. (2019). Visfatin induces inflammation and insulin resistance via the NF-κB and STAT3 signaling pathways in hepatocytes. Journal of diabe